SCHEMBL1502018

SCHEMBL1502018

Nc1c(Cl)cc(C(=O)O)c2c1CCO2

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 7/20 0.51
HTR3A P46098 2/20 0.51
HTR3E A5X5Y0 1/20 0.51
HTR3B O95264 1/20 0.51
HTR3D Q70Z44 1/20 0.51
HTR3C Q8WXA8 1/20 0.51
HTR1A P08908 1/20 0.47
ADRA2C P18825 1/20 0.47
ACHE P22303 1/20 0.47
PTGS1 P23219 1/20 0.47
ADRA1A P35348 1/20 0.47
KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316552 0.91 HTR4 (0.47) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL7333211 0.90 HTR4 (0.46) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL8509459 0.89 HTR4 (0.52) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL5042500 0.88 HTR4 (0.51) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL14810412 0.84 HTR4 (0.59) HTR4HTR3AHTR3EHTR3BHTR3D
Hydrochloric Acid SCHEMBL7365194 0.82 HTR4 (0.51) HTR4HTR3AHTR3EHTR3BHTR3D
Hydrochloric Acid SCHEMBL7361286 0.82 HTR4 (0.44) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL5042523 0.82 HTR4 (0.54) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL2944408 0.82 HTR4 (0.50) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL27942442 0.81 SMN1; SMN2 (0.41) HTR4HTR3AHTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3413891-B1 PROCESSES FOR THE PREPARATION OF HIGHLY PURE PRUCALOPRIDE SUCCINATE SYMED LABS LTD (IN) 2024-01-03 EP claimed
CN-115745929-A Preparation method of prankari succinate key intermediate 山东四环药业股份有限公司 2023-03-07 CN claimed
CN-111298127-A Composition comprising histamine release-promoting substance and inhibitory compound, and oral solid preparation containing the same 黄泳华 2020-06-19 CN claimed
EP-3413891-A1 PROCESSES FOR THE PREPARATION OF HIGHLY PURE PRUCALOPRIDE SUCCINATE AND ITS INTERMEDIATES Symed Labs Limited (IN) 2018-12-19 EP claimed
WO-2017137910-A1 PROCESSES FOR THE PREPARATION OF HIGHLY PURE PRUCALOPRIDE SUCCINATE AND ITS INTERMEDIATES SYMED LABS LIMITED (IN) 2017-08-17 WO claimed
EP-0885190-B1 N-SUBSTITUTED 4-((4'-AMINOBENZOYL)-OXYMETHYL)-PIPERIDINES HAVING GASTRIC PROKINETIC PROPERTIES JANSSEN PHARMACEUTICA NV (BE) 2003-05-07 EP claimed
CN-1068881-C Phenyl-oxo-alkyl-(4-piperidinyl) benzoate derivs. JANSSEN PHARMACEUTICA NV (BE) 2001-07-25 CN claimed
EP-0784620-B1 N-SUBSTITUTED PIPERIDINYL BICYCLIC BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 1999-12-08 EP claimed
EP-0784619-B1 PHENYL-OXO-ALKYL-(4-PIPERIDINYL)BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 1999-03-24 EP claimed
CN-1160401-A Phenyl-oxo-alkyl- (4-piperidinyl) benzoate derivatives JANSSEN PHARMACEUTICA NV (BE) 1997-09-24 CN claimed
EP-0784619-A1 PHENYL-OXO-ALKYL-(4-PIPERIDINYL)BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1997-07-23 EP claimed
US-5616738-A A 7-CARBOXYBENZOFURAN INTERMEDIATE FOR DRUGS HAVING GASTROINTESTINAL MOTILITY STIMULATING PROPERTIES JANSSEN PHARMACEUTICA N.V. (BE) 1997-04-01 US claimed
WO-1996010026-A1 PHENYL-OXO-ALKYL-(4-PIPERIDINYL)BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1996-04-04 WO claimed
US-4950766-A Preparation of benzamides useful as antiemetic agents ERBAMONT, INC. (US) 1990-08-21 US claimed
EP-0314483-A1 Preparation of benzamides ERBAMONT, INC. (US) 1989-05-03 EP claimed
EP-4541794-A1 PHENYL-SUBSTITUTED DIHYDRONAPHTHYRIDINE COMPOUNDS, AND PREPARATION AND USE THEREOF Suzhong Pharmaceutical Group Co., Ltd. (CN) 2025-04-23 EP disclosed
CN-119707895-A Preparation method of 7-formyl-2, 3-dihydrobenzofuran-4-carbonitrile 江苏苏中药业研究院有限公司 2025-03-28 CN disclosed
US-4888353-A Carboxamides useful as antiemetic or antipsychotic agents ERBAMONT, INC. (US) 1989-12-19 US disclosed
EP-0314483-A1 Preparation of benzamides ERBAMONT, INC. (US) 1989-05-03 EP disclosed
EP-0234872-A1 Carboxamides useful as antiemetic or antipsychotic agents Erbamont Inc. (US) 1987-09-02 EP disclosed